May 11, 2022 / 05:40PM GMT
Kevin Mark Fischbeck - BofA Securities, Research Division - MD in Equity Research
[Audio Gap]
to introducing Cigna. Cigna is one of the largest health insurers and (inaudible) pharmacy benefit management companies. Presenting today, we have Brian Evanko, CFO. We also have Ralph Giacobbe, from the Investor Relations as well. I think we should go right into Q&A.
Questions and Answers:
Kevin Mark Fischbeck - BofA Securities, Research Division - MD in Equity ResearchSo I guess, first, on the Commercial side of business. During the quarter the guidance, probably (inaudible) coming in stronger than we thought. So can you talk a little bit about what drove the outperformance in the Commercial membership, let's start there.
Brian C. Evanko - Cigna Corporation - Executive VP & CFO
Sure. Good morning, everybody. Great to be here, face-to-face as well. So thanks for hosting us. But our Commercial membership in the first quarter came in a bit stronger than we expected. And for the full year across Cigna
Trustpilot
